PhRMA rushes out; They're paid to do this

The Pharmaceutical Research and Manufacturers of America (PhRMA) is expected to unveil its legislative agenda formally at a press conference this week, but drafts of its FDA reform bill have been floating around Washington for weeks.

The draft bill is an amalgam of last year's Senate and House bills. Provisions include: imposing performance standards on the agency; changing the statutory basis for regulating biologicals to achieve uniform

Read the full 662 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers